CBD Oil 3000mg – Full Spectrum

Description

Full spectrum CBD oil represents the most comprehensive cannabinoid formulation available in hemp-derived products. This product delivers 3000 mg of cannabidiol in a 50 ml bottle, providing a concentration of 60 mg per millilitre alongside a complete profile of naturally occurring cannabinoids, terpenes, and flavonoids. Unlike broad spectrum or isolate formulations, full spectrum CBD retains trace amounts of THC (below 0.3%), which is insufficient to produce psychoactive effects but contributes to the entourage effect—a phenomenon where cannabinoids and terpenes work synergistically to enhance overall bioavailability and interaction with the body’s endocannabinoid system.

The extraction process relies on supercritical CO₂ technology, a solvent-free method that isolates cannabinoids from hemp biomass under precisely controlled temperature and pressure conditions. This technique selectively extracts cannabinoids, terpenes, and flavonoids while removing unwanted plant lipids, waxes, and chlorophyll. The result is a refined oil that preserves the full chemical complexity of the hemp plant, delivering a multi-compound formulation that supports the entourage effect. The absence of alcohol or hydrocarbon solvents ensures that the final product is free from residual contaminants and maintains the integrity of heat-sensitive terpenes and cannabinoids.

Full spectrum CBD oil is often preferred by experienced cannabinoid users who value the complete plant profile and are comfortable with trace THC content within legal limits. The THC present in this formulation is naturally occurring and falls well below the 0.3% threshold established by industrial hemp regulations in Australia and most international jurisdictions. This trace level of THC is non-intoxicating and does not produce the psychoactive effects associated with higher-THC cannabis products. However, users subject to workplace drug testing should exercise caution, as even trace amounts of THC may be detected in sensitive screening methods.

Manufacturing, Quality Assurance, and Cannabinoid Synergy

The carrier oil used in this formulation is MCT (medium-chain triglycerides), derived from fractionated coconut oil. MCT oil is selected for its rapid absorption rate, neutral flavour, and ability to enhance the bioavailability of lipophilic (fat-soluble) cannabinoids. When administered sublingually, the oil is held under the tongue for 30 to 60 seconds, allowing cannabinoids and terpenes to be absorbed directly through the mucous membranes into the bloodstream. This sublingual delivery method bypasses hepatic first-pass metabolism, leading to faster onset and more efficient absorption compared to oral ingestion or capsule formats.

Manufacturing takes place in an EU-based clean room facility that adheres to Good Manufacturing Practice (GMP) standards. Clean room environments control airborne particulates, temperature, humidity, and microbial contamination to ensure consistent production conditions. GMP compliance involves rigorous quality control at every stage, including raw material verification, in-process testing, and final product analysis. Each batch undergoes third-party laboratory testing for cannabinoid potency, terpene profiles, heavy metals, pesticides, residual solvents, and microbial contaminants. Batch-specific Certificates of Analysis (COA) should be verified directly through the manufacturer’s website to confirm cannabinoid content and purity.

CBD interacts with the endocannabinoid system, which is present in all mammals. The presence of minor cannabinoids (CBG, CBC, CBN) and terpenes (myrcene, limonene, caryophyllene) further enhances the entourage effect. However, it is critical to emphasise that CBD oil is not intended to diagnose, treat, cure, or prevent any disease. Users should approach cannabinoid supplementation with appropriate caution and consult healthcare professionals before use, particularly if taking prescription medications or managing chronic health conditions.

Dosage, Storage, and Legal Considerations

Dosage protocols for full spectrum CBD oil vary based on individual factors such as body weight, metabolism, prior cannabinoid exposure, and wellness goals. Many users begin with a conservative dose of 0.25 to 0.5 ml (15 to 30 mg CBD) once or twice daily and adjust gradually based on personal response. Consistency in timing and dosage helps maintain stable cannabinoid levels in the system. Users should avoid exceeding recommended serving sizes without professional guidance, as higher doses do not necessarily correlate with improved outcomes.

Storage recommendations include keeping the bottle in a cool, dark environment away from direct sunlight, heat sources, and moisture. Glass dropper bottles provide protection against light degradation, but prolonged exposure to heat can still compromise cannabinoid and terpene potency. Once opened, the product should be used within six months to ensure freshness and optimal efficacy. In warmer climates (such as much of Australia), refrigeration may extend shelf life, but the oil should be allowed to return to room temperature before use to ensure accurate dosing consistency.

This 3000 mg full spectrum CBD oil is positioned as a mid-tier strength option suitable for users transitioning from lower-potency formulations or those seeking a more concentrated dose without reaching maximum available strengths. The combination of trace THC content, naturally occurring terpenes, and supercritical CO₂ extraction provides a comprehensive cannabinoid experience for informed consumers navigating the hemp-derived product market.

Aurum Australis offers this premium full spectrum CBD oil as part of a curated selection designed for Australian consumers who value cannabinoid diversity, plant synergy, and regulatory compliance. Explore our full range of CBD formulations—including broad spectrum and isolate options—to find the cannabinoid profile that aligns with your needs.

Frequently Asked Questions (FAQ)

What is the entourage effect, and why does full spectrum CBD oil provide it?

The entourage effect is a hypothesis suggesting that cannabinoids, terpenes, and flavonoids work synergistically to enhance overall bioavailability and interaction with the endocannabinoid system. Full spectrum CBD oil retains the complete profile of naturally occurring hemp compounds, including trace amounts of THC (< 0.3%), minor cannabinoids (CBG, CBC, CBN), and terpenes (myrcene, limonene, caryophyllene). This multi-compound formulation is believed to produce more comprehensive effects than CBD isolate or single-cannabinoid products. Broad spectrum oils offer a similar cannabinoid diversity but with all THC removed, making full spectrum the most complete option for users comfortable with trace THC content within legal limits.

Will full spectrum CBD oil with trace THC make me fail a drug test?

Full spectrum CBD oil contains trace amounts of THC (below 0.3%), which is insufficient to produce psychoactive effects but may be detected in sensitive workplace drug screenings. While the THC content is minimal and legally compliant in Australia under TGA regulations, drug tests vary in sensitivity, and some may detect even trace levels of THC metabolites. Users subject to workplace drug testing should consider broad spectrum (THC-free) or CBD isolate formulations as safer alternatives. Always verify batch-specific Certificates of Analysis (COA) to confirm THC content, and consult with employers or legal advisors regarding cannabinoid product use policies.

How should I determine the right dosage for full spectrum CBD oil?

Dosage for full spectrum CBD oil depends on individual factors such as body weight, metabolism, prior cannabinoid experience, and wellness goals. A common starting point is 0.25 to 0.5 ml (15 to 30 mg CBD) once or twice daily, taken sublingually by holding the oil under the tongue for 30 to 60 seconds before swallowing. Monitor your body’s response for several days before adjusting the dose incrementally. Consistency in timing and dosage helps maintain stable cannabinoid levels. Always consult with a healthcare professional before starting any cannabinoid regimen, particularly if you’re taking prescription medications or managing chronic health conditions. Higher doses do not always equate to better outcomes, so gradual adjustment is key.